Home » Topics » Regulatory » Patents

Patents
RSS

IRL patents cortical cathecolaminergic neurotransmission modulators

Dec. 16, 2016

Chong Kun Dang Holdings divulges new histone deacetylase inhibitors

Dec. 15, 2016

Principia Biopharma patents new FGFR inhibitors

Dec. 15, 2016

Merck & Co. discovers soluble guanylate cyclase activators

Dec. 15, 2016

Harvard and Evotec divulge novel bacterial glycosyl transferase inhibitors

Dec. 15, 2016

TSRI, Icahn School of Medicine and UPenn patent nAChR modulators

Dec. 15, 2016

Shanghai Institute Materia Medica develops tyrosine kinase inhibitors

Dec. 15, 2016

Chinese scientists patent FGFR inhibitors

Dec. 14, 2016

Idenix Pharmaceuticals and Southern Research Institute disclose nucleoside derivatives

Dec. 14, 2016

Novogen presents TMP3 inhibitors

Dec. 14, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...